Analystreport

Cascadian Therapeutics, Inc. (NASDAQ: CASC) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.

CASCADIAN THERAPEUTICS INC  (CASC) 
Last cascadian therapeutics inc earnings: 11/8 04:01 pm Check Earnings Report
US:NYSE Investor Relations: ir.cascadianrx.com